Verified
The first week involved more planning than I expected. I checked cold medicine and stopped using an alcohol-based mouthwash. The tablet helped me take abstinence seriously, but counselling made the bigger difference.
15 Sept 2026
Active ingredient: Disulfiram
Antabuse
Quality products
24/7 Support
Fast delivery
Delivery
from 4 days
Antabuse is a prescription tablet for adults receiving structured treatment for alcohol dependence. Its disulfiram ingredient supports abstinence by blocking alcohol breakdown and causing an unpleasant reaction if alcohol is consumed.
Description
Antabuse is a prescription medicine containing disulfiram for adults receiving structured treatment for alcohol dependence. Disulfiram belongs to a different pharmacological group from medicines that reduce craving through opioid or glutamate pathways. Its main action is enzyme inhibition rather than direct control of reward signalling in the brain.
Composition
Antabuse tablets contain disulfiram, an aldehyde dehydrogenase inhibitor used as an abstinence-support treatment in alcohol dependence. The dose is stated on the pack — follow the leaflet. Its role is deterrence: exposure to alcohol during treatment can produce a rapid and uncomfortable reaction.
| Active substance | Drug class | Form |
|---|---|---|
| Disulfiram — dose stated on the pack | Aldehyde dehydrogenase inhibitor | Oral tablet |
Disulfiram is not a medicine that removes alcohol cravings on its own. It creates a strong physical consequence if alcohol enters the body, so treatment works best when the person understands the reaction, wants to remain abstinent, and has continuing clinical and psychological support.
Disulfiram belongs to a different pharmacological group from medicines that reduce craving through opioid or glutamate pathways. Its main action is enzyme inhibition rather than direct control of reward signalling in the brain.
Active Ingredient Specification
The active ingredient is disulfiram. After oral administration, it is absorbed and converted into metabolites that interfere with aldehyde dehydrogenase, an enzyme involved in alcohol metabolism.
The tablet strength requires careful dosing decisions. A clinician may choose a different schedule during treatment, depending on liver function, treatment stage, adherence, and the person’s risk of alcohol exposure. The tablet should not be divided, crushed, or adjusted unless the prescriber has given specific instructions.
Alcohol can be present in products that do not feel alcoholic, including some cough mixtures, mouthwashes, sauces, desserts, cooking extracts, and liquid medicines. Ask specifically about alcohol-containing products before starting disulfiram.
Dosage and usage
The prescribed dose must come from the clinician managing alcohol-dependence treatment. The dose is stated on the pack — follow the leaflet. The prescribing schedule may vary during initiation, maintenance, supervised dosing, or dose reduction.
General administration principles include:
- Take the tablet by mouth exactly as prescribed.
- Do not start treatment while alcohol may still be present in the body.
- Do not drink alcohol during treatment.
- Avoid alcohol-containing medicines, foods, cosmetics, and household products.
- If a dose is missed, do not double the next dose.
- Contact the prescribing service for missed-dose instructions, especially when supervised dosing forms part of the recovery plan.
- Continue alcohol avoidance after stopping disulfiram because sensitivity can persist.
A clinician may arrange liver-function testing before treatment and during follow-up. The schedule depends on the patient’s medical history and treatment plan.
Keep a written alcohol-avoidance list in your phone. Include mouthwash, liquid cold remedies, cooking wine, alcohol-based tinctures, and products labelled ethanol, alcohol, or ethyl alcohol.
How it works
The liver normally breaks ethanol into acetaldehyde through alcohol dehydrogenase. Aldehyde dehydrogenase then converts acetaldehyde into acetate, which the body can process further.
Disulfiram blocks aldehyde dehydrogenase. If alcohol is consumed, acetaldehyde rises in the bloodstream. This can cause facial flushing, headache, nausea, vomiting, sweating, palpitations, shortness of breath, low blood pressure, and marked discomfort. The reaction can begin within minutes and may last for several hours.
The medicine does not neutralise alcohol already consumed. It changes the body’s response to alcohol after exposure. A reaction can occur with small quantities, and sensitivity may continue for up to two weeks after disulfiram is stopped, as described in regulatory prescribing information [2].
Indications
Antabuse is used as part of a planned treatment programme for alcohol dependence. It is most suitable when the patient has chosen abstinence and understands that alcohol must be avoided during treatment and for a period after the final dose.
Disulfiram does not treat alcohol withdrawal. A person who drinks heavily every day may need medically supervised withdrawal management before disulfiram begins. Starting it while alcohol remains in the body can trigger a serious reaction.
Treatment programmes may include:
- Medical assessment before the first dose.
- Screening for liver disease and other conditions.
- Counselling or cognitive behavioural therapy.
- Relapse-prevention planning.
- Support from addiction services or a structured recovery programme.
- Follow-up appointments to assess adherence and adverse effects.
- Practical planning for alcohol exposure at home, work, restaurants, and social events.
The National Institute for Health and Care Excellence describes psychological treatment, relapse prevention, and medicines as parts of a wider approach to alcohol dependence rather than isolated solutions [1].
Disulfiram suits some patients because the deterrent effect is clear and immediate after alcohol exposure. It suits others poorly when adherence is unreliable, alcohol access is frequent, or the patient has significant liver disease.
Before treatment starts, make a written list of medicines, supplements, mouth products, and personal-care products used regularly. Alcohol exposure can occur through more than drinks alone.
Comparison
Disulfiram differs from craving-focused treatments:
| Treatment approach | Main pharmacological idea | Practical limitation |
|---|---|---|
| Disulfiram | Produces an aversive reaction after alcohol exposure | Requires reliable abstinence and adherence |
| Acamprosate-type treatment | Helps stabilise glutamate and GABA signalling during abstinence | Does not create an immediate alcohol reaction |
| Opioid-antagonist treatment | Reduces some rewarding effects of alcohol | May be unsuitable with certain opioid medicines or liver conditions |
This comparison describes treatment categories rather than a personal recommendation. The choice depends on liver and kidney function, opioid use, withdrawal history, adherence, pregnancy status, and the patient’s recovery plan.
Contraindications
Antabuse is not suitable for everyone. This medication is not for you if:
- You have consumed alcohol recently and have not completed the required alcohol-free interval.
- You have severe liver disease or active hepatitis without specialist assessment.
- You have serious heart disease or significant coronary disease.
- You have psychosis that is not adequately controlled.
- You have had a severe reaction to disulfiram or a related compound.
- You are unable to understand or follow the requirement to avoid alcohol.
- You are pregnant or breastfeeding unless a specialist has assessed the balance of risks and benefits.
Disulfiram can interact with medicines and substances. Important examples include:
- Warfarin, because anticoagulant effects may increase.
- Phenytoin, because blood concentrations may rise.
- Isoniazid, which may increase neurological effects.
- Metronidazole, which may contribute to confusion or psychotic symptoms.
- Certain benzodiazepines, because sedation or altered metabolism may occur.
- Medicines containing alcohol.
- Products containing paraldehyde or related alcohol-containing ingredients.
Disulfiram may also interfere with the metabolism of some medicines. A complete medicines review is needed before the first dose. A person taking opioid pain medicines should disclose this before switching to another alcohol-dependence treatment, since opioid-antagonist medicines have different restrictions.
When this is not for you
This treatment may not be appropriate if you have recently consumed alcohol, serious liver or heart problems, uncontrolled psychosis, or a previous severe reaction to disulfiram. It may also be unsafe if you cannot reliably avoid alcohol or are using medicines that can interact with it. Pregnancy and breastfeeding require specialist advice before treatment.
Side effects
Some people experience side effects even when they do not drink alcohol. Possible effects include tiredness, headache, metallic or garlic-like taste, drowsiness, stomach discomfort, nausea, skin rash, and reduced sexual interest.
More serious reactions can involve the liver or nervous system. Symptoms requiring prompt medical assessment include:
- Yellowing of the skin or eyes.
- Dark urine or pale stools.
- Persistent nausea or loss of appetite.
- Pain under the right ribs.
- Severe tiredness or unusual weakness.
- Tingling, numbness, or weakness in the limbs.
- Confusion, visual changes, or seizures.
- Severe rash or facial swelling.
Liver injury may develop without dramatic early symptoms, which is why clinical monitoring matters. The FDA prescribing information identifies hepatic toxicity as a significant risk of disulfiram treatment [3].
An alcohol-disulfiram reaction may include flushing, throbbing headache, sweating, rapid heartbeat, nausea, vomiting, dizziness, fainting, and breathing difficulty. Severe reactions can affect blood pressure and the heart.
A mild metallic taste can be annoying but is different from signs of liver injury. Yellow eyes, dark urine, or persistent vomiting should not be managed by simply skipping a dose.
Common mistakes
Several practical mistakes can increase the chance of harm or treatment failure:
- Starting too soon after drinking. Disulfiram should not be started while alcohol remains in the body.
- Assuming small amounts are harmless. A small quantity of alcohol can provoke a strong reaction.
- Forgetting non-beverage alcohol. Mouthwash, liquid medicines, sauces, and extracts may contain ethanol.
- Stopping after a few alcohol-free days. The deterrent effect depends on continued adherence.
- Doubling a missed dose. This can increase adverse effects without improving protection.
- Hiding disulfiram from the prescriber. New medicines may interact with it.
- Ignoring liver symptoms. Yellowing eyes, dark urine, and unusual weakness require medical review.
- Treating the tablet as a cure. Counselling and relapse-prevention work remain important.
- Sharing tablets. The medicine may be unsuitable for another person’s liver, heart, psychiatric, or medication history.
One less obvious mistake is using an alcohol-containing topical product repeatedly over large areas of broken skin. The practical risk varies by product and exposure, so the exact ingredients should be discussed with the treatment team before use.
What doctors say
In clinical practice, doctors usually view disulfiram as an adherence-dependent treatment. Its pharmacology is clear, but its benefit depends on a person taking it consistently and avoiding alcohol-containing products.
A doctor may ask:
- Has the patient completed alcohol withdrawal?
- Is the patient committed to abstinence?
- Is there reliable family or service support?
- Are liver tests acceptable?
- Could another medicine provide a better fit?
- Is supervised dosing appropriate?
- Does the patient understand the duration of alcohol sensitivity after stopping?
Disulfiram may be useful when a clear deterrent supports a person’s recovery plan. It may be unsuitable when treatment is taken secretly, when drinking continues, or when medical follow-up is unlikely.
The World Health Organization describes alcohol-dependence care as a combination of clinical management, psychosocial support, and continuing follow-up; the National Institute on Alcohol Abuse and Alcoholism similarly emphasizes combined medical and behavioural support. That model is more realistic than expecting one tablet to resolve a long-standing addiction [4].
Frequently asked questions
How long does disulfiram remain active after the last tablet?
Alcohol sensitivity can continue for up to 14 days after stopping disulfiram. The FDA prescribing information from 2023 describes this persistence because enzyme activity does not return immediately after the medicine is discontinued. Alcohol should remain completely avoided during this period.
Can Antabuse be taken during alcohol withdrawal?
Disulfiram is not a treatment for acute alcohol withdrawal. NICE guidance from 2011 recommends assessment of withdrawal severity and appropriate medical management before a relapse-prevention medicine is started. Tremor, sweating, agitation, hallucinations, seizures, or confusion can signal a medical emergency.
Can alcohol be consumed while taking Antabuse?
Alcohol should be avoided during treatment and after the final dose. The disulfiram-ethanol reaction may involve flushing, vomiting, low blood pressure, breathing difficulty, and cardiovascular complications. The FDA identifies this reaction as a central safety feature and risk of disulfiram treatment in its 2023 prescribing information.
Does Antabuse remove alcohol cravings?
Disulfiram does not directly remove cravings. It creates a deterrent by blocking aldehyde dehydrogenase, while counselling and relapse-prevention strategies address triggers and behavioural patterns. The WHO alcohol-treatment framework published in 2016 supports combining medicines with psychosocial care rather than relying on pharmacotherapy alone.
What monitoring is used during treatment?
A clinician may assess liver function, psychiatric symptoms, adherence, alcohol exposure, and other medicines. Follow-up is also used to review symptoms such as numbness, visual changes, severe fatigue, or abdominal discomfort. The European Medicines Agency’s pharmacovigilance principles from 2017 support ongoing assessment when a medicine can cause clinically significant liver reactions [5].
What happens if a dose is missed?
Do not take two tablets to compensate for a missed dose. The correct response depends on the prescribed schedule, whether dosing is supervised, and how long the dose was delayed. NICE guidance from 2011 supports obtaining a restart plan from the treatment service, especially when several doses have been missed.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Antabuse: Reviews and Experiences
3.7
Based on 5 reviews
Verified
I missed two doses during a work trip and did not take extra tablets. The treatment service advised me how to restart. I found the metallic taste unpleasant, although it became less noticeable.
24 Sept 2026
Verified
The medicine helped because my family supervised the doses. I still had cravings during stressful evenings, so the relapse plan and support meetings were necessary.
29 Sept 2026
Verified
I developed nausea and unusual tiredness. The clinic arranged blood tests and reviewed the medicine rather than telling me to push through it. That was reassuring.
04 Oct 2026
Verified
I expected the tablet to remove the urge to drink. It did not. It gave me a strong reason to avoid alcohol while I worked on the causes of my drinking.
11 Oct 2026
Sources
- National Institute for Health and Care Excellence (2011). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115)
- U.S. Food and Drug Administration (2023). Antabuse (disulfiram) Tablets, USP Prescribing Information
- U.S. Food and Drug Administration (2023). Disulfiram Drug Label Information
- World Health Organization (2016). mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings
- European Medicines Agency (2017). Guideline on good pharmacovigilance practices: Module V — Risk management systems
